Back

EHRA PATHS: multimorbidity, polypharmacy and sex differences in atrial fibrillation (AF) patients: unmet needs and how to improve.

3 April 2022 (15:57 - 16:09)
Organised by:
Congress Presentation Part of: The EHRA EU research projects European Heart Rhythm Association (EHRA) Open Access EHRA 2022

About the speaker

Photo
Professor Hein Heidbuchel

University Hospital Antwerp, Edegem (Belgium)

4 More presentations in this session

Presentation thumbnail
AFEECT EU: cost benefits and acceptability of atrial fibrillation (AF) screening across different Europe.
Professor R. Schnabel (Hamburg, DE)
Slides Video
Presentation thumbnail
PROFID: risk score to predict the individual sudden cardiac death (SCD) risk and identify those post-MI patients that will optimally benefit from an implantable cardioverter defibrillator (ICD).
Doctor N. Dagres (Berlin, DE)
Slides Video
Presentation thumbnail
ESCAPE-NET: towards a personalised risk score for sudden cardiac arrest.
Doctor H. Tan (Amsterdam, NL)
Slides Video
Presentation thumbnail
The EHRA EU research projects - discussion.

Access the full session

Session thumbnail
The EHRA EU research projects
Video

The Event

Event poster

EHRA 2022

3 April 2022 15:57 CET
You may be interested in
thumbnail
Congress Session
General Assembly
thumbnail
ESC TV Today
Episode 13: Current indications for pulmonary vein isolation - Conduction system pacing
thumbnail
Congress Session
General Assembly

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources